Liver transplantation outcome in patients with angiographically proven coronary artery disease: A multi-institutional study

American Journal of Transplantation

Volumn 13, Issue 1, 2013, Pages 184-191

  Wray, C ^a   Scovotti, J C ^a   Tobis, J ^a   Niemann, C U ^b   Planinsic, R ^c   Walia, A ^d   Findlay, J ^e   Wagener, G ^f   Cywinski, J B ^g   Markovic, D ^a   Hughes, C ^c   Humar, A ^c   Olmos, A ^b   Sierra, R ^d   Busuttil, R ^a   Steadman, R H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e Mayo Clinic College of Medicine   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Coronary artery disease; end stage liver disease; liver transplantation; mortality; survival

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; SURGICAL RISK; TREATMENT OUTCOME;

EID: 84871823789     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04293.x     Document Type: Article

References (29)

1. Carey WD, Dumot JA, Pimentel RR, et al.. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59: 859-864.
2. Keeffe BG, Valantine H, Keeffe EB,. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001; 7: 755-761.
3. Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al.. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 2006; 98: 178-181.
4. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y,. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 426-430.
5. Harinstein ME, Flaherty JD, Ansari AH, et al.. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant 2008; 8: 1523-1528.
6. Diedrich DA, Findlay JY, Harrison BA, Rosen CB,. Influence of coronary artery disease on outcomes after liver transplantation. Transplant Proc 2008; 40: 3554-3557.
7. Yong CM, Sharma M, Ochoa V, et al.. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transplant 2010; 16: 1242-1248.
8. Ehtisham J, Altieri M, Salame E, Saloux E, Ollivier I, Hamon M,. Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management. Liver Transplant 2010; 16: 550-557.
9. Raval Z, Harinstein ME, Skaro AI, et al.. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 2011; 58: 223-231.
10. Lentine KL, Costa SP, Weir MR, et al.. Cardiac disease evaluation and management among kidney and liver transplantation candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2012; 60: 434-480.
11. Donovan CL, Marcovitz PA, Punch JD, et al.. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 1180-1188.
12. Plotkin JS, Benitez RM, Kuo PC, et al.. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 1998; 4: 253-257.
13. Tsutsui JM, Mukherjee S, Elhendy A, et al.. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transplant 2006; 12: 592-599.
14. Davidson CJ, Gheorghiade M, Flaherty JD, et al.. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol 2002; 89: 359-360.
15. Aydinalp A, Bal U, Atar I, et al.. Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates. Transplant Proc 2009; 41: 3757-3760.
16. Anonymous. Scientific Registry of Transplant Recipients. 2012 Available at: http://www.srtr.org/csr/current/modtabs.aspx. Accessed February 10, 2012.
17. Desai NM, Mange KC, Crawford MD, et al.. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004; 77: 99-106.
18. Olthoff KM, Brown RS, Delmonico FL, et al.. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. Liver Transplant 2004; 10: A6-A22.
19. Bashore TM, Bates ER, Berger PB, et al.. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001; 37: 2170-2214.
20. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL,. 7-year survival of patients with normal or near normal coronary arteriograms-a CASS registry study. J Am Coll Cardiol 1986; 7: 479-483.
21. Baptista J, Arnese M, Roelandt JR, et al.. Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: Correlations with dobutamine-atropine stress test. J Am Coll Cardiol 1994; 23: 1434-1439.
22. Lozner EC, Johnson LW, Johnson S, et al.. Coronary arteriography 1984-1987: A report of the Registry of the Society for Cardiac Angiography and Interventions: II. An analysis of 218 deaths related to coronary arteriography. Cathet Cardiovasc Diagn 1989; 17: 11-14.
23. Lipshutz GS, Busuttil RW,. Liver transplantation in those of advancing age: The case for transplantation. Liver Transplant 2007; 13: 1355-1357.
24. Keswani RN, Ahmed A, Keeffe EB,. Older age and liver transplantation: A review. Liver Transplant 2004; 10: 957-967.
25. Turner TB, Bennett VL, Hernandez H,. The beneficial side of moderate alcohol use. Johns Hopkins Med J 1981; 148: 53-63.
26. Stettler C, Wandel S, Allemann S, et al.. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.
27. Serruys PW, Ong ATL, van Herwerden LA, et al.. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease-The final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581.
28. Rabkin JM, Corless CL, Rosen HR, Olyaei AJ,. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg 2002; 183: 595-599.
29. OPTN / SRTR 2010 Annual Data Report. 2011; Available at: http://www.srtr.org/annual-reports/2010/flash/03-liver/index.html. Accessed June 21, 2012.